[Featured Stock] Andyforce Surges on Mass Production of COVID-19 and Flu Simultaneous Diagnostic Kits
[Asia Economy Reporter Geum Bo-ryeong] AndyForce surged sharply on the afternoon of the 24th following news that it will mass-produce a kit that simultaneously diagnoses COVID-19 and influenza.
At 2:33 PM that day, AndyForce's stock price rose 11.65% (920 KRW) from the previous close to 8,820 KRW.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- [Seoul, Now] Redevelopment Speed Pledge No.1: Without On-Site Insight, It Becomes the First Failure
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
AndyForce announced that it began mass production of the "COVID-19 and Influenza Combo Diagnostic Kit" for overseas export on the same day. This kit can detect infections of COVID-19 as well as Influenza A and B at once.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
